Delivery Order SPE2DB25D3002-SPE2DB25FLPUW

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,456.37 firm fixed-price delivery order is for the provision of IMOVAX Rabies Vaccine Vials. The contract has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $11,166.50, is for the delivery of IMOVAX Rabies Vaccine Vials. This is a firm fixed-price Delivery Order contract with a completion date of December 11, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award is for the delivery of IMOVAX Rabies vaccine vials to the Defense Logistics Agency (DLA). The contract, valued at $1,339.98, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed-price pricing type and an ultimate completion date of December 10, 2024. The contract is a delivery order and is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $6,801.92 firm-fixed-price delivery order is for the supply of IMOVAX rabies vaccine vials, with a completion date of July 15, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This single-award IDC...
The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies. The contract, valued at $3,669.79, is for the provision of IMOVAX Rabies Vaccine vials. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at up to $999,999,999.00 through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,004.75 firm fixed-price delivery order is for the supply of IMOVAX Rabies Vaccine Vials. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award is for the delivery of IMOVAX Rabies Vaccine Vials to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $4,128.11, was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is May 31, 2024. The contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,563.31 Firm Fixed Price Delivery Order contract is for the provision of IMOVAX Rabies Vaccine Vials, with a performance period ending on November 27, 2024. This contract was not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of IMOVAX Rabies Vaccine Vials, with a ceiling value of $5,583.25 and a performance period ending on December 10, 2024. This contract is a delivery order placed under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November...
This federal contract award is for the delivery of IMOVAX RABIES VACCINE VIALS to the Defense Logistics Agency (DLA). The $1,295.22 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that supplies medical products to federal government agencies. The contract has an ultimate completion date of October 25, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
  • SPE2DB25D3002
    Indefinite Delivery Contract
  • SPE2DB25D3002-SPE2DB25FLPUW
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, worth $10,941.27, is for the delivery of IMOVAX Rabies Vaccine Vials under a Firm Fixed Price Delivery Order contract. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The awarded contract does not have a set-aside designation, indicating it was open competition.

Generated 4/4/25, 9:42 AM